Reducing the costs of medicine by dispensing generic medicine 25 September 2013 Presented by:...
-
Upload
zayne-walle -
Category
Documents
-
view
214 -
download
0
Transcript of Reducing the costs of medicine by dispensing generic medicine 25 September 2013 Presented by:...
![Page 1: Reducing the costs of medicine by dispensing generic medicine 25 September 2013 Presented by: Christo Rademan – Managing Director.](https://reader037.fdocuments.net/reader037/viewer/2022110205/56649cb05503460f94974ffb/html5/thumbnails/1.jpg)
Reducing the costs of medicine by dispensing
generic medicine
25 September 2013
Presented by:Christo Rademan – Managing Director
![Page 2: Reducing the costs of medicine by dispensing generic medicine 25 September 2013 Presented by: Christo Rademan – Managing Director.](https://reader037.fdocuments.net/reader037/viewer/2022110205/56649cb05503460f94974ffb/html5/thumbnails/2.jpg)
Contents
1. Where does the data come from?
2. Legislation regarding generic substitution
3. Generic utilisation trends in Namibia
4. Factors that drive generic utilisation
5. Measures to promote generic utilisation
![Page 3: Reducing the costs of medicine by dispensing generic medicine 25 September 2013 Presented by: Christo Rademan – Managing Director.](https://reader037.fdocuments.net/reader037/viewer/2022110205/56649cb05503460f94974ffb/html5/thumbnails/3.jpg)
Mediscor PBM
• Pharmaceutical Benefit Management Company
• Experienced – was established in 1989 and has been
in business for more than 24 years
• An independent company with 119 staff members
• 85 Clients: medical schemes, insurance products,
sick funds, price files
• More than 1.6 million lives
• Namibia: 4 open & closed schemes
![Page 4: Reducing the costs of medicine by dispensing generic medicine 25 September 2013 Presented by: Christo Rademan – Managing Director.](https://reader037.fdocuments.net/reader037/viewer/2022110205/56649cb05503460f94974ffb/html5/thumbnails/4.jpg)
• Medicines and Related substances control Act,
2003 (Act 13 of 2003)
• Came into effect August 2008
“A pharmacist must inform all members of the public of the benefits of substituting the requested medicine with
an interchangeable multi-source medicine”
“And may dispense an interchangeable multi-source medicine instead of the medicine on the prescription”
Legislation: Mandatory generic substitution
![Page 5: Reducing the costs of medicine by dispensing generic medicine 25 September 2013 Presented by: Christo Rademan – Managing Director.](https://reader037.fdocuments.net/reader037/viewer/2022110205/56649cb05503460f94974ffb/html5/thumbnails/5.jpg)
• Namibia 31-45%
• RSA 53%
• USA 70%+
Generic utilisation rate (2013)
![Page 6: Reducing the costs of medicine by dispensing generic medicine 25 September 2013 Presented by: Christo Rademan – Managing Director.](https://reader037.fdocuments.net/reader037/viewer/2022110205/56649cb05503460f94974ffb/html5/thumbnails/6.jpg)
Generic utilisation
trends
![Page 7: Reducing the costs of medicine by dispensing generic medicine 25 September 2013 Presented by: Christo Rademan – Managing Director.](https://reader037.fdocuments.net/reader037/viewer/2022110205/56649cb05503460f94974ffb/html5/thumbnails/7.jpg)
Generic utilisation trendsSouth Africa
0
10
20
30
40
50
60
70
80
Per
cen
tage
Generic equivalents Branded products - valid patent
Branded products - patent expired % Generisized
73.2%
43.0%
53.4%
27.7%19.8%
15.3%
26.8%
57.0%
![Page 8: Reducing the costs of medicine by dispensing generic medicine 25 September 2013 Presented by: Christo Rademan – Managing Director.](https://reader037.fdocuments.net/reader037/viewer/2022110205/56649cb05503460f94974ffb/html5/thumbnails/8.jpg)
Generic utilisation – SA vs. Namibia
40
42
44
46
48
50
52
54
56
Perc
enta
ge
South Africa Namibia
![Page 9: Reducing the costs of medicine by dispensing generic medicine 25 September 2013 Presented by: Christo Rademan – Managing Director.](https://reader037.fdocuments.net/reader037/viewer/2022110205/56649cb05503460f94974ffb/html5/thumbnails/9.jpg)
Generic utilisation trendsNamibia
40
45
50
55
60
65
Perc
enta
ge
Generic utilisation rate % Generisized
47.5%
44.9%
61.9%61.1%
Legislation had no impact
![Page 10: Reducing the costs of medicine by dispensing generic medicine 25 September 2013 Presented by: Christo Rademan – Managing Director.](https://reader037.fdocuments.net/reader037/viewer/2022110205/56649cb05503460f94974ffb/html5/thumbnails/10.jpg)
Generic utilisation trendsNamibia
0
10
20
30
40
50
60
70
Perc
enta
ge
Generic equivalents % Generisized
Originals - expired patent Originals - valid patent
61.1%
47.5% 44.9%
38.1%
16.2%14.7%
38.9%
61.9%
![Page 11: Reducing the costs of medicine by dispensing generic medicine 25 September 2013 Presented by: Christo Rademan – Managing Director.](https://reader037.fdocuments.net/reader037/viewer/2022110205/56649cb05503460f94974ffb/html5/thumbnails/11.jpg)
Generic utilisation 2013
% Expenditure % Volume
34.4
18.5
47.2
Generic equivalents Original - expired patent Original - valid patent
44.9
16.2
38.9
![Page 12: Reducing the costs of medicine by dispensing generic medicine 25 September 2013 Presented by: Christo Rademan – Managing Director.](https://reader037.fdocuments.net/reader037/viewer/2022110205/56649cb05503460f94974ffb/html5/thumbnails/12.jpg)
Generic utilisationPer benefit category (2013)
0
10
20
30
40
50
60
Perc
enta
ge
Acute Chronic Oncology OTC Other HIV
![Page 13: Reducing the costs of medicine by dispensing generic medicine 25 September 2013 Presented by: Christo Rademan – Managing Director.](https://reader037.fdocuments.net/reader037/viewer/2022110205/56649cb05503460f94974ffb/html5/thumbnails/13.jpg)
Generic medicines as a source of affordable health care
1.58(N$141.63)
1.48(N$132.74)
1.00 (N$89.42)
Originals - valid patent
Originals - expired patent
Generic equivalents
Based on 2013 data
![Page 14: Reducing the costs of medicine by dispensing generic medicine 25 September 2013 Presented by: Christo Rademan – Managing Director.](https://reader037.fdocuments.net/reader037/viewer/2022110205/56649cb05503460f94974ffb/html5/thumbnails/14.jpg)
0
50
100
150
200
Generics Original - expiredpatent
Original - valid patent
Rand /
N$
South Africa Namibia
Cost per item – SA vs. Namibia
R1.00
R1.39
R2.52
N$1.00
N$1.51
N$1.72
![Page 15: Reducing the costs of medicine by dispensing generic medicine 25 September 2013 Presented by: Christo Rademan – Managing Director.](https://reader037.fdocuments.net/reader037/viewer/2022110205/56649cb05503460f94974ffb/html5/thumbnails/15.jpg)
Namibia RSA
SEP +
50% Mark-up+
Dispensing fee (N$4.50)+
Broken bulk
SEP < R100: 28%SEP ≥ R100: R28
Current dispensing fee structure – SA vs. Namibia
NB: Namibian fee structure rewards dispensing expensive products
![Page 16: Reducing the costs of medicine by dispensing generic medicine 25 September 2013 Presented by: Christo Rademan – Managing Director.](https://reader037.fdocuments.net/reader037/viewer/2022110205/56649cb05503460f94974ffb/html5/thumbnails/16.jpg)
Government Gazette, 19 November 2010
Single Exit Price (SEP) band (incl. VAT)
Fixed fee (excl. VAT)
% Mark-up on SEP (excl. VAT)
<R75 R6 46%
≥R75 to <R200 R15.75 33%
≥R200 to <R700 R51 15%
≥R700 R121 5%
SA maximum legislated dispensing fee
![Page 17: Reducing the costs of medicine by dispensing generic medicine 25 September 2013 Presented by: Christo Rademan – Managing Director.](https://reader037.fdocuments.net/reader037/viewer/2022110205/56649cb05503460f94974ffb/html5/thumbnails/17.jpg)
Data: Namibian Medical Scheme
Ingredient cost band
% Items
% Ingre-dient cost
Ingre-dient
cost per item (N$)
Current mark-up fee structure
Proposed 1: GG 33775, 19 Nov 2010
Fee per item (N$)
% Mark-up
Fee per item (N$)
% Mark-up
% Diff. in total cost
% Diff. in fee per
item
Less than N$75 67.2 26.0 36.06 18.03 50.0 25.81 71.6 14.4 43.1
≥ N$75 and < N$200
23.7 31.2 122.76 61.38 50.0 64.29 52.4 1.6 4.7
≥ N$200 and < N$700
8.6 28.4 306.04 153.02 50.0 110.98 36.3 -9.2 -27.5
≥ N$700 0.5 14.3 2 643.89 1 321.95 50.0 289.85 11.0 -26.0 -78.1
Total 100.0 100.0 93.06 46.53 50.0 43.61 46.9 -2.1 -6.3
Impact of SA max legislated dispensing fee on Namibia
![Page 18: Reducing the costs of medicine by dispensing generic medicine 25 September 2013 Presented by: Christo Rademan – Managing Director.](https://reader037.fdocuments.net/reader037/viewer/2022110205/56649cb05503460f94974ffb/html5/thumbnails/18.jpg)
Factors that drive / influence generic utilisation
• Availability of generic alternatives
• Mandatory generic substitution
• Prescriber and provider education / attitudes
• Provider incentives
• Procurement behaviour of providers
• Consumer education
• Funder rules / benefit design Generic reference pricing
Formularies
![Page 19: Reducing the costs of medicine by dispensing generic medicine 25 September 2013 Presented by: Christo Rademan – Managing Director.](https://reader037.fdocuments.net/reader037/viewer/2022110205/56649cb05503460f94974ffb/html5/thumbnails/19.jpg)
Measures to promote generic
utilisation
![Page 20: Reducing the costs of medicine by dispensing generic medicine 25 September 2013 Presented by: Christo Rademan – Managing Director.](https://reader037.fdocuments.net/reader037/viewer/2022110205/56649cb05503460f94974ffb/html5/thumbnails/20.jpg)
Success is achieved by
engaging all the role
players
![Page 21: Reducing the costs of medicine by dispensing generic medicine 25 September 2013 Presented by: Christo Rademan – Managing Director.](https://reader037.fdocuments.net/reader037/viewer/2022110205/56649cb05503460f94974ffb/html5/thumbnails/21.jpg)
Promoting generic utilisation - funders
Active pharmacy managementEngaging roll players to promote generic utilisationProvider engagement – actively monitor pharmacy performance
• Applying management tools (Patient Experience
Monitor)
• Monitoring co-payments at the point of service
• Engaging with pharmacy to change dispensing
behaviour
• Specifying acceptable, cost-effective products
during chronic authorisation
![Page 22: Reducing the costs of medicine by dispensing generic medicine 25 September 2013 Presented by: Christo Rademan – Managing Director.](https://reader037.fdocuments.net/reader037/viewer/2022110205/56649cb05503460f94974ffb/html5/thumbnails/22.jpg)
Promoting generic utilisation - funders
Member engagement – inform member of cost-
effective generic alternatives
• Promote high-performing pharmacies by area
• Communicating these pharmacies via the
authorization process
• SMS messaging to members regarding co-
payments
• Communicating quarterly with pharmacies
![Page 23: Reducing the costs of medicine by dispensing generic medicine 25 September 2013 Presented by: Christo Rademan – Managing Director.](https://reader037.fdocuments.net/reader037/viewer/2022110205/56649cb05503460f94974ffb/html5/thumbnails/23.jpg)
Tools to measure and model pharmacy behaviour
![Page 24: Reducing the costs of medicine by dispensing generic medicine 25 September 2013 Presented by: Christo Rademan – Managing Director.](https://reader037.fdocuments.net/reader037/viewer/2022110205/56649cb05503460f94974ffb/html5/thumbnails/24.jpg)
Objectives:
• To actively work with Pharmacy to optimize
dispensing behaviour
• To reduce member co-payments, driving the
concept of a ‘wallet-free’ experience
• To drive generic substitution towards the use of
Mediscor reference price (MRP) products
• To drive members towards network pharmacies
Ensures cost-effective delivery of benefits
Mediscor Pharmacy Management
![Page 25: Reducing the costs of medicine by dispensing generic medicine 25 September 2013 Presented by: Christo Rademan – Managing Director.](https://reader037.fdocuments.net/reader037/viewer/2022110205/56649cb05503460f94974ffb/html5/thumbnails/25.jpg)
• Measures the ideal behaviour per line That can be rolled up by Option, Pharmacy, Group, etc.
Very powerful
• Enables meaningful engagement at Pharmacy
level
• Enables network contracting and management
Provides the ability to form preferred partnerships
Value of PEM – Optimizes the experience
![Page 26: Reducing the costs of medicine by dispensing generic medicine 25 September 2013 Presented by: Christo Rademan – Managing Director.](https://reader037.fdocuments.net/reader037/viewer/2022110205/56649cb05503460f94974ffb/html5/thumbnails/26.jpg)
Tools to measure and model pharmacy behaviour
![Page 27: Reducing the costs of medicine by dispensing generic medicine 25 September 2013 Presented by: Christo Rademan – Managing Director.](https://reader037.fdocuments.net/reader037/viewer/2022110205/56649cb05503460f94974ffb/html5/thumbnails/27.jpg)
Generic efficiency
![Page 28: Reducing the costs of medicine by dispensing generic medicine 25 September 2013 Presented by: Christo Rademan – Managing Director.](https://reader037.fdocuments.net/reader037/viewer/2022110205/56649cb05503460f94974ffb/html5/thumbnails/28.jpg)
• Generic utilisation decreased over the past 4 years
• 16% of volume is from brands with patent expired
• Multiple factors influence generic utilisation
• Legislation had no impact!
• Behaviour change needs to be driven by:
Rewards & incentives
Education
Provider engagement
• Misalignment of provider and funder interests to be
resolved
Conclusion
![Page 29: Reducing the costs of medicine by dispensing generic medicine 25 September 2013 Presented by: Christo Rademan – Managing Director.](https://reader037.fdocuments.net/reader037/viewer/2022110205/56649cb05503460f94974ffb/html5/thumbnails/29.jpg)
Thank you!
Any Questions?